{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:41:00Z","timestamp":1761946860545,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejmech.2022.114471","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T02:37:50Z","timestamp":1653014270000},"page":"114471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features"],"prefix":"10.1016","volume":"238","author":[{"given":"Shenghua","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letian","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-613X","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114471_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","article-title":"Antivirals: past, present and future","volume":"85","author":"De Clercq","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114471_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11904-019-00480-3","article-title":"Recent advances in the development of integrase inhibitors for HIV treatment","volume":"17","author":"Trivedi","year":"2020","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.ejmech.2022.114471_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41589-020-0496-y","article-title":"HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes","volume":"16","author":"Xiao","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114471_bib4","doi-asserted-by":"crossref","first-page":"12730","DOI":"10.1021\/acs.chemrev.6b00125","article-title":"Retroviral DNA integration","volume":"116","author":"Lesbats","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114471_bib5","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/acs.jmedchem.8b00843","article-title":"The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic","volume":"62","author":"Namasivayam","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114471_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.apsb.2012.02.008","article-title":"Prodrug design, synthesis and pharmacokinetic evaluation of (3\u2019R, 4\u2019R)-3-hydroxymethyl-4-methyl-3\u2019,4\u2019-di-O-(S)-camphanoyl-(+)-cis-khellactone","volume":"2","author":"Guo","year":"2012","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejmech.2022.114471_bib8","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/med.20241","article-title":"HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design","volume":"33","author":"Zhan","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114471_bib9","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1021\/ja4018418","article-title":"Thermodynamics of HIV-1 reverse transcriptase in action elucidates the mechanism of action of non-nucleoside inhibitors","volume":"135","author":"Bee","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114471_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17425255.2019.1673367","article-title":"Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment","volume":"15","author":"Wang","year":"2019","journal-title":"Expert. Opin. Drug. Met."},{"key":"10.1016\/j.ejmech.2022.114471_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/2040206617753443","article-title":"Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors","volume":"26","author":"Famiglini","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2022.114471_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/430741","article-title":"Emergence of drug-resistant HIV-1 after intrapartum administration of singledose nevirapine is substantially underestimated","volume":"192","author":"Johnson","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114471_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","article-title":"Molecular basis of human immunodefificiency virus type 1 drug resistance: overview and recent developments","volume":"98","author":"Menendez-Arias","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2022.114471_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/092986711794839142","article-title":"Recent advances in DAPYs and related analogues as HIV-1 NNRTIs","volume":"18","author":"Chen","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib15","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1021\/acs.jmedchem.8b01729","volume":"62","author":"Huang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib17","article-title":"Surveillance of HIV transmitted drug resistance in Latin america and the caribbean: a systematic review and meta-analysis","volume":"11","author":"Santiago","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114471_bib18","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2022.114471_bib19","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","article-title":"Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design","volume":"53","author":"Lansdon","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2796.2007.01910.x","article-title":"The first postmodern pandemic: 25 years of HIV\/AIDS","volume":"263","author":"Kallings","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejmech.2022.114471_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2022.114471_bib22","first-page":"901","article-title":"Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance","volume":"11","author":"Grant","year":"2010","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2022.114471_bib23","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2174\/092986709788803231","article-title":"Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update","volume":"16","author":"Zhan","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/jm00061a022","article-title":"5-chloro-3-(Arenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase","volume":"36","author":"Williams","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/jm040854k","article-title":"Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives","volume":"48","author":"Ragno","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2016.10.009","article-title":"Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement","volume":"126","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111619","article-title":"Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing","volume":"182","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib28","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1021\/jm300477h","article-title":"New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 nonnucleoside reverse transcriptase inhibitors","volume":"55","author":"Regina La","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib29","first-page":"A71","article-title":"Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide","volume":"90","author":"Regina La","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib30","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1039\/C9OB00032A","article-title":"Targeting the hydroArobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus","volume":"17","author":"Zhou","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2022.114471_bib31","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.bmcl.2014.06.081","article-title":"The use of spirocyclic scaffolds in drug discovery","volume":"24","author":"Zheng","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114471_bib32","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.drudis.2020.07.017","article-title":"Fsp3: a new parameter for drug-likeness","volume":"25","author":"Wei","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114471_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ejmech.2022.114471_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2022.114471_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-0934(93)90054-U","article-title":"Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase","volume":"44","author":"Suzuki","year":"1993","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ejmech.2022.114471_bib37","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ejmech.2007.12.015","article-title":"Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents","volume":"43","author":"Rawal","year":"2008","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422003737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422003737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:13:05Z","timestamp":1728396785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422003737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":36,"alternative-id":["S0223523422003737"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114471","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114471"}}